Targeted lung cancer drug wows meetingPromising early trial results for crizotinib highlighted in plenary session Tool aids ovarian CA screening Many NPs lack oncology expertise: study Supervising physicians act as educators for NPs new to oncology. Yondelis approved for relapsed ovarian cancer New drug delivery system: the nanosponge? Elderly lung cancer patients benefit from aggressive chemo 'Remarkable' four-month improvement in survival will change practice, researchers say Radiation-hormone therapy combo best for high-risk prostate cancer Sponge-derived drug extends breast cancer survival Breast density decrease linked with lower cancer risk Targeted therapy battles late-stage lung cancer Researchers tailor treatment to tumour’s molecular signature Tamoxifen vs. raloxifene: Which is best for breast cancer prevention? Followup study further delineates the differences in effectiveness and toxicity between the two selective estrogen receptor modulators Heat-activated chemotherapy for liver tumours on the horizon First Previous 63 64 65 66 67 Next Last
